Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07059312
PHASE1

A Phase 1 Study of JADE101 in Healthy Participants

Sponsor: Jade Biosciences, Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.

Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2025-08-17

Completion Date

2026-10

Last Updated

2025-12-18

Healthy Volunteers

Yes

Interventions

DRUG

JADE101

JADE101 is supplied as sterile solution to be administered by SC injection.

DRUG

Placebo

Placebo solution to be administered at a matching volume by SC injection.

Locations (1)

NZCR

Auckland, New Zealand